Strategies for Coping with Pancreatic Cancer
- Conditions
- C25Malignant neoplasm of pancreas
- Registration Number
- DRKS00020251
- Lead Sponsor
- Hochschule Osnabrück, University of Applied Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
People suffering from adenocarcinoma of the pancreas, possibly other persons according to the circular research process of Grounded Theory Methodology
Exclusion Criteria
Other pancreatic (tumor) disease, inability to consent, lack of informed consent, withdrawn consent
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Target criterion is data saturation regarding the research questions. Interviews with patients and relatives can be conducted at any stage of the disease or at any time after diagnosis or during/after therapy.
- Secondary Outcome Measures
Name Time Method Development of a theory for coping with pancreatic cancer
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie coping strategies in pancreatic cancer patients enrolled in DRKS00020251?
How do coping strategies in DRKS00020251 compare to standard-of-care psychological interventions for pancreatic cancer?
Are there specific biomarkers associated with effective coping in malignant neoplasm of pancreas C25 as studied in DRKS00020251?
What adverse events are reported in observational studies of pancreatic cancer coping interventions like DRKS00020251?
What combination therapies or supportive care approaches correlate with improved outcomes in DRKS00020251 pancreatic cancer study?